ENHANCED GENOMICS LIMITED
Research and experimental development on biotechnology
ENHANCED GENOMICS LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Suite 1, The Jeffreys Building, St John's Innovation Park Cowley Road Cambridge Cambridgeshire CB4 0DS United Kingdom
Full company profile for ENHANCED GENOMICS LIMITED (12423696), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 24 Jan 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Cash in Bank
£1.93M
Net Assets
£3.69M
Total Liabilities
£346.53k
Turnover
N/A
Employees
28
Debt Ratio
9%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (4)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 3 | Jan 2021 | Series A, Seed |
| Investor 5 | Jan 2021 | Seed |
| Investor 1 | Oct 2022 | Series A |
See all 4 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Parkwalk Advisors Ltd | Corporate-director | United Kingdom | Unknown | 25 Aug 2022 | Active |
See all 19 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Bgf Investment Management Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Mnl (parkwalk) Nominees Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Bioqube Factory Fund I Commv
Ceased 2 Sept 2022
Peter John Fraser
Ceased 1 Apr 2021
Peter John Fraser
Ceased 5 Aug 2020
Stefan Walter Schoenfelder
Ceased 5 Aug 2020
Mikhail Spivakov
Ceased 5 Aug 2020
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 21 Mar 2026 | Resolution | Resolutions | |
| 17 Mar 2026 | Officers | Termination of Dietrich Stephan as director on 2026-03-13 | |
| 17 Mar 2026 | Officers | Termination of Katerina Leftheris as director on 2026-03-09 | |
| 18 Feb 2026 | Confirmation Statement | Confirmation statement made on 2026-02-03 with updates | |
| 17 Feb 2026 | Officers | Appointment of Katerina Leftheris as director on 2026-01-19 |
Resolutions
Termination of Dietrich Stephan as director on 2026-03-13
Termination of Katerina Leftheris as director on 2026-03-09
Confirmation statement made on 2026-02-03 with updates
Appointment of Katerina Leftheris as director on 2026-01-19
Recent Activity
Latest Activity
Resolutions
1 months ago on 21 Mar 2026
Termination of Dietrich Stephan as director on 2026-03-13
1 months ago on 17 Mar 2026
Termination of Katerina Leftheris as director on 2026-03-09
1 months ago on 17 Mar 2026
Confirmation statement made on 2026-02-03 with updates
2 months ago on 18 Feb 2026
Appointment of Katerina Leftheris as director on 2026-01-19
2 months ago on 17 Feb 2026